Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder
David Coghill(The University of Melbourne), Alessandro Zuddas(University of Cagliari), Tobias Banaschewski(Heidelberg University), César A. Soutullo(The University of Texas Health Science Center), Matthew G. Cottingham(University of Oxford)
Cited by 120
Related Papers
Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders
|Cell|2019|1.5k
The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder
|Neuroscience & Biobehavioral Reviews|2021|1.4k
Attention-deficit/hyperactivity disorder
|Nature Reviews Disease Primers|2015|1.3k
Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis
|The Lancet Psychiatry|2017|884
Meta-Analysis of Genome-Wide Association Studies of Attention-Deficit/Hyperactivity Disorder
|Journal of the American Academy of Child & Adolescent Psychiatry|2010|469